Pon1 and Sult1a1 Polymorphisms and Breast Cancer Among Young Women in Brazil

被引:0
作者
da Costa, Rafaela Soares Senra [1 ]
Souza, Nara de Almeida [1 ]
Zukeram, Ketiuce de Azevedo [2 ]
Freire, Carmen [3 ]
Jacome, Guillermo Patricio Ortega [4 ]
Koifman, Rosalina Jorge [1 ,2 ]
Cardoso, Cynthia Chester [5 ]
Santos, Sabrina da Silva [1 ,2 ]
机构
[1] Oswaldo Cruz Fdn FIOCRUZ, Programa Posgrad Saude Publ & Meio Ambiente, Publ Hlth & Environm Postgrad Program, PPGSPMA,Natl Publ Hlth Sch ENSP,Escola Nacl Saude, Rio De Janeiro, Brazil
[2] Oswaldo Cruz Fdn FIOCRUZ, Natl Sch Publ Hlth ENSP, Dept Epidemiol & Quantitat Methods Hlth DEMQS, Dept Epidemiol & Metodos Quantitat Saude, Rio De Janeiro, Brazil
[3] Univ Granada, Biosanit Res Inst ibs granada, Dept Legal Med & Toxicol, CIBER Epidemiol & Publ Hlth, Granada, Spain
[4] Presidente Antonio Carlos Univ UNIPAC, Juiz De Fora, Brazil
[5] Univ Fed Rio de Janeiro UFRJ, Inst Biol, Lab Virol Mol, Rio De Janeiro, Brazil
关键词
breast cancer; PON1; genetic polymorphism; young women; OBESITY-RELATED GENES; PARAOXONASE; SERUM PARAOXONASE; ARG(213)HIS POLYMORPHISM; RISK; ASSOCIATION; SULFOTRANSFERASES; SUSCEPTIBILITY; L55M; DNA;
D O I
10.1089/jayao.2023.0176
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the association of genetic polymorphisms Gln(192)Arg and Leu(55)Met of Paraoxonase 1 (PON1) gene, and Arg(213)His of Sulfotransferase 1A1 (SUT1A1) gene with occurrence of breast cancer among young women living in Rio de Janeiro city. Methods: This is a hospital-based case-control study including 265 women aged 18-35 years, diagnosed with breast cancer at National Cancer Institute; and 277 controls in the same age group selected among women patients and companions of three general hospitals from Rio de Janeiro public health network. Polymorphisms genotyping was performed using the PCR-RFLP technique. Results: For PON1 gene, breast cancer women had a greater chance of being homozygote for Leu(55)Met polymorphism (ORadjusted = 1.42, 95% CI= 0.67-3.00, recessive model) and a lower chance of having at least one allele of Gln(192)Arg polymorphism (ORadjusted = 0.75, 95% CI = 0.50-1.13, dominant model), but without statistical significance. Accordingly, frequency of the haplotype Met(55)/Arg(192) was lower among breast cancer women, but no statistically significant association was observed (ORadjusted = 0.85; 95% CI = 0.48-1.51). SULT1A1 His/His genotype was significantly associated with a protective effect for breast cancer (OR (adjusted) = 0.51, 95% CI = 0.28-0.91, recessive model). Conclusion: Arg(213)His polymorphism of SUT1A1 gene showed a protective effect against breast cancer among Brazilian young women. More studies with different designs are needed to understand the role of PON1 and SULT1A1 polymorphisms in breast cancer development in young Brazilian women.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 51 条
[1]   Breast cancer in young women: an overview [J].
Anastasiadi, Zoi ;
Lianos, Georgios D. ;
Ignatiadou, Eleftheria ;
Harissis, Haralampos V. ;
Mitsis, Michail .
UPDATES IN SURGERY, 2017, 69 (03) :313-317
[2]   Breast Cancer Before Age 40 Years [J].
Anders, Carey K. ;
Johnson, Rebecca ;
Litton, Jennifer ;
Phillips, Marianne ;
Bleyer, Archie .
SEMINARS IN ONCOLOGY, 2009, 36 (03) :237-249
[3]   CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study [J].
Antognelli, Cinzia ;
Del Buono, Chiara ;
Ludovini, Vienna ;
Gori, Stefania ;
Talesa, Vincenzo N. ;
Crino, Lucio ;
Barberini, Francesco ;
Rulli, Antonio .
BMC CANCER, 2009, 9
[4]   Sulfotransferase 1A1 Arg213His polymorphism and prostate cancer risk [J].
Arslan, Serdal ;
Silig, Yavuz ;
Pinarbasi, Hatice .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (06) :1159-1162
[5]   An investigation of the relationship between SULT1A1 Arg213His polymorphism and lung cancer susceptibility in a Turkish population [J].
Arslan, Serdal ;
Silig, Yavuz ;
Pinarbasi, Hatice .
CELL BIOCHEMISTRY AND FUNCTION, 2009, 27 (04) :211-215
[6]  
Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335
[7]   Association between L55M polymorphism in Paraoxonase 1 and cancer risk: a meta-analysis based on 21 studies [J].
Chen, Lei ;
Lu, Wei ;
Fang, Lu ;
Xiong, Hu ;
Wu, Xun ;
Zhang, Meng ;
Wu, Song ;
Yu, Dexin .
ONCOTARGETS AND THERAPY, 2016, 9 :1151-1158
[8]   Endocrine therapy for breast cancer: an overview [J].
Cheung, K. L. .
BREAST, 2007, 16 (04) :327-343
[9]   Cancer and molecular biomarkers of phase 2 [J].
Dalhoff, K ;
Jensen, KB ;
Poulsen, HE .
PHASE II CONJUGATION ENZYMES AND TRANSPORT SYSTEMS, 2005, 400 :618-627
[10]   Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study [J].
DeRoo, Lisa A. ;
Bolick, Sophia C. E. ;
Xu, Zongli ;
Umbach, David M. ;
Shore, David ;
Weinberg, Clarice R. ;
Sandler, Dale P. ;
Taylor, Jack A. .
CARCINOGENESIS, 2014, 35 (02) :333-338